Table 3 Clinical and pathological data
Fatty liver (n = 45) | Non-fatty liver (n = 47) | p value | |
|---|---|---|---|
Age (year), mean ± SD, range | 60.7 ± 8.3 (40–80) | 59.4 ± 10.6 (15–77) | 0.931 |
Sex | |||
Male | 38 (84.4) | 34 (72.3) | 0.159 |
Female | 7 (15.6) | 13 (27.7) | |
Risk factors | |||
HBV | 13 (28.9) | 15 (31.9) | 0.753 |
HCV | 30 (66.7) | 28 (59.6) | 0.481 |
Alcohol intake | 0 (0) | 3 (6.4) | 0.242* |
Clinical and laboratory data | |||
Duration of symptoms (months); median (IQR) | 14 (8.5.-17.5) | 12 (8–18) | 0.503# |
HTN | 28 (62.2) | 28 (59.6) | 0.795 |
DM | 27 (60) | 29 (61.7) | 0.867 |
BMI (kg/m2), mean ± SD | 33.7 (± 4) | 32.5 (± 4.5) | 0.181** |
Elevated α-fetoprotein level | 18 (40) | 24 (51.1) | 0.287 |
Elevated alanine transaminase (ALT) level | 13 (28.9) | 25 (53.2) | 0.018 |
Elevated aspartate transaminase (AST) level | 11 (24.4) | 23 (48.9) | 0.015 |